Cargando…

Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition

BACKGROUND: Antimicrobial stewardship programs promote de-escalation: moving from broad to narrow spectrum agents and/or stopping antibiotics as more clinical data return. A standard definition of de-escalation objectively applied to electronic data could provide a means to assess stewardship improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Moehring, Rebekah W, Ren, Xinru, Anderson, Deverick J, Davis, Angelina, Dyer, April, Lokhnygina, Yuliya, Hicks, Lauri, Srinivasan, Arjun, Ashley, Elizabeth Dodds
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631635/
http://dx.doi.org/10.1093/ofid/ofx162.070
_version_ 1783269520724459520
author Moehring, Rebekah W
Ren, Xinru
Anderson, Deverick J
Davis, Angelina
Dyer, April
Lokhnygina, Yuliya
Hicks, Lauri
Srinivasan, Arjun
Ashley, Elizabeth Dodds
author_facet Moehring, Rebekah W
Ren, Xinru
Anderson, Deverick J
Davis, Angelina
Dyer, April
Lokhnygina, Yuliya
Hicks, Lauri
Srinivasan, Arjun
Ashley, Elizabeth Dodds
author_sort Moehring, Rebekah W
collection PubMed
description BACKGROUND: Antimicrobial stewardship programs promote de-escalation: moving from broad to narrow spectrum agents and/or stopping antibiotics as more clinical data return. A standard definition of de-escalation objectively applied to electronic data could provide a means to assess stewardship improvement opportunities. METHODS: We performed a retrospective cohort study of de-escalation events among five hospitals from the Duke Health System and the Duke Antimicrobial Stewardship Outreach Network using 2016 electronic medication administration record data. Antibiotics were ranked into four categories: narrow spectrum (e.g., cefazolin), broad spectrum, extended spectrum, and agents typically targeted for protection (e.g., meropenem). Included patients were cared for on inpatient units, had antibiotic therapy for at least 2 days, and had at least 3 days of hospitalization after starting antibiotics. De-escalation was defined as reduction in either the number of antibiotics or rank measured at two time points: day 1 of initiation of antibiotic therapy and day 5 (or day of discharge if occurring on day 3 or 4). Escalation was an increase in either number or rank of agents. Unchanged was either no change or discordant directions of change in number and rank. For all categories, the outcome was percent among qualifying admissions. Descriptive statistics were used to describe de-escalation among hospitals, unit type, and ICD-10 diagnoses. RESULTS: Among 39,226 included admissions, de-escalation occurred in 14,138 (36%), escalation in 5,129 (13%), and antibiotics were unchanged in 19,959 (51%) (Figure). Percent de-escalation was significantly different among hospitals (median 37%, range 31–39%, P < .001). Infectious diagnoses with lower rates of de-escalation included intra-abdominal infection (23%), skin and soft-tissue infection (28%), and ENT/upper respiratory tract infection (19%). Intensive care units had higher rates of both de-escalation and escalation (43% and 16%) when compared with non-ICU wards (35% and 13%, P < .001). CONCLUSION: We provided an objective, electronic definition of de-escalation and demonstrated variation among hospitals, units, and diagnoses. This metric may be useful for assessing stewardship opportunities. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631635
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56316352017-11-07 Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition Moehring, Rebekah W Ren, Xinru Anderson, Deverick J Davis, Angelina Dyer, April Lokhnygina, Yuliya Hicks, Lauri Srinivasan, Arjun Ashley, Elizabeth Dodds Open Forum Infect Dis Abstracts BACKGROUND: Antimicrobial stewardship programs promote de-escalation: moving from broad to narrow spectrum agents and/or stopping antibiotics as more clinical data return. A standard definition of de-escalation objectively applied to electronic data could provide a means to assess stewardship improvement opportunities. METHODS: We performed a retrospective cohort study of de-escalation events among five hospitals from the Duke Health System and the Duke Antimicrobial Stewardship Outreach Network using 2016 electronic medication administration record data. Antibiotics were ranked into four categories: narrow spectrum (e.g., cefazolin), broad spectrum, extended spectrum, and agents typically targeted for protection (e.g., meropenem). Included patients were cared for on inpatient units, had antibiotic therapy for at least 2 days, and had at least 3 days of hospitalization after starting antibiotics. De-escalation was defined as reduction in either the number of antibiotics or rank measured at two time points: day 1 of initiation of antibiotic therapy and day 5 (or day of discharge if occurring on day 3 or 4). Escalation was an increase in either number or rank of agents. Unchanged was either no change or discordant directions of change in number and rank. For all categories, the outcome was percent among qualifying admissions. Descriptive statistics were used to describe de-escalation among hospitals, unit type, and ICD-10 diagnoses. RESULTS: Among 39,226 included admissions, de-escalation occurred in 14,138 (36%), escalation in 5,129 (13%), and antibiotics were unchanged in 19,959 (51%) (Figure). Percent de-escalation was significantly different among hospitals (median 37%, range 31–39%, P < .001). Infectious diagnoses with lower rates of de-escalation included intra-abdominal infection (23%), skin and soft-tissue infection (28%), and ENT/upper respiratory tract infection (19%). Intensive care units had higher rates of both de-escalation and escalation (43% and 16%) when compared with non-ICU wards (35% and 13%, P < .001). CONCLUSION: We provided an objective, electronic definition of de-escalation and demonstrated variation among hospitals, units, and diagnoses. This metric may be useful for assessing stewardship opportunities. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631635/ http://dx.doi.org/10.1093/ofid/ofx162.070 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Moehring, Rebekah W
Ren, Xinru
Anderson, Deverick J
Davis, Angelina
Dyer, April
Lokhnygina, Yuliya
Hicks, Lauri
Srinivasan, Arjun
Ashley, Elizabeth Dodds
Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition
title Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition
title_full Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition
title_fullStr Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition
title_full_unstemmed Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition
title_short Can antibiotic De-escalation Be Measured Without Chart Review? A Proposed Electronic Definition
title_sort can antibiotic de-escalation be measured without chart review? a proposed electronic definition
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631635/
http://dx.doi.org/10.1093/ofid/ofx162.070
work_keys_str_mv AT moehringrebekahw canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT renxinru canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT andersondeverickj canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT davisangelina canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT dyerapril canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT lokhnyginayuliya canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT hickslauri canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT srinivasanarjun canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition
AT ashleyelizabethdodds canantibioticdeescalationbemeasuredwithoutchartreviewaproposedelectronicdefinition